The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost-effective for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology.

First a little explanation about the new unique product with its own delivery system. This is not only a medication but also a matchstick-sized osmotic mini pump that is the size of a match and is placed just beneath the skin to deliver a continuous and consistent flow of medication for a year.

Study announces a new benefit in addition to reductions in major adverse cardiovascular events.

Does liraglutide help in the reduction of cardiovascular diseases?

Alogliptin is efficient and safe in the management of type 2 diabetes even in patients who have cardiovascular disease as a comorbidity.

Is semaglutide a better way to manage type 2 diabetes?

Dr. Jovanovic discusses the safety of diabetes medications during pregnancy, and advocates that insulin is the only treatment that is truly safe.

Exclusive Interview from AACE Orlando This is a 5-part transcript. Part 1 | Part 2 | Part 3 | Part 4 | Part 5 Steve Freed: Well, it’s a real honor to be here at AACE 2016 at Orlando. And to be with probably the most knowledgeable person when it …

A new weight loss device, AspireAssist, offers a novel approach to cutting calories: draining them from the stomach before they are fully digested. The AspireAssist® system consists of a thin tube implanted in the stomach, connecting to an outside port on the skin of the belly.

We certainly have important education to accomplish with patients and health professionals regarding the new higher concentration insulin products that are available only in a pen, including U-300 TOUJEO (insulin glargine), U-200 TRESIBA (insulin degludec), and U-200 HUMALOG (insulin lispro). U-500 insulin is also available in a pen (HUMULIN), although vials remain on the market. Patients may not understand proper dosing and dose measurement with these higher concentrations of insulin products.